panakés partners

The Universal Remedy In European Medtech Industry

Venture Capital investments in startup and high-growth SMEs in Europe & Israel

   

About us

Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick.

Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel.

Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development.

We seek and help to grow Medtech companies with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties.
From our office in Milan, Panakes is willing to back the smartest entrepreneurs with the best technologies and ideas.

   

Our Approach

Investment Focus
Investment Focus
  • Medical Device
  • Medical Diagnostics
  • Biotech for in-vitro diagnostics
  • Healthcare-IT
  • Innovative medical services
Our Advantages
Our Advantages
  • Broad Network of Business Contacts and Corporate Relations
  • Deep Domain Expertise
  • Proactive Portfolio Management
  • Strong relationship with selected industrial partners
We are looking for
We are looking for
  • Unique technologies solving medical industry real problem
  • Strong teams with deep knowledge of the industry
  • Clear competitive advantage and sizable market potential
  • Companies in need of capital to accelerate market acceptance
   

Team

Alessio Beverina linkedin Alessio Beverina mail
Alessio Beverina
Alessio Beverina
founder and Managing Partner
  • Former Partner at Sofinnova Partners
  • Invested followed and exited over 10 Start-ups & SMEs in Europe
  • Deep knowledge of technology development acquired through several roles at leading Electronics companies and Labs (STM, LETI)
  • Msc in Chemical Engineering @ Politecnico di Milano and MBA ESCP-EAP, Kauffman Fellow
Fabrizio Landi linkedin Fabrizio Landi mail
Fabrizio Landi
Fabrizio Landi
founder and Managing Partner
  • Former Managing Director and General Manager at Esaote
  • Serving as director of several corporate and institutions
  • Deep knowledge of the market acquired through several roles at leading healthcare companies (Bayer, Esaote, Bracco, Menarini)
  • Msc in BioEngineering @ Politecnico di Milano
Diana Saraceni linkedin Matteo Panfilo mail
Diana Saraceni
Diana Saraceni
founder and Managing Partner
  • Co-Founder & Former Managing Partner at 360 Capital Partners
  • 15 years of Venture Capital experience, invested in a significant number of companies in Italy and all over Europe not only in the medical device sector, and generated several exits as IPO and M&A transactions
  • Strong Knowledge of the Venture Capital community in Italy/Europe
  • Msc in Engineering @ LaSapienza and MBA Luiss University
Barbara Castellano linkedin Barbara Castellano mail
Barbara Castellano
Barbara Castellano
Principal
  • Former CEO Techwald
  • Former Director Clinical Affairs, Certifications and Registrations, Quality Assurance CID SpA
  • Former Director Business Development, Heart Valves BU at Sorin
  • Strong Knowledge in the cardiovascular sector
  • Msc in Medicinal Chemistry and Technology @ University of Perugia and MBASDA Bocconi
Francesco Panfilo linkedin Francesco Panfilo mail
Francesco Panfilo
Francesco Panfilo
President
  • Former Founding Managing Partner and Chairman of PM & Partners SpA.
  • Former Managing Director at ABN AMRO Capital Investments (Italy)
  • Former Chief Executive Officer at SOFIPA
  • Spent seven years working for multinational industrial engineering companies (Technip and Foster Wheeler)
  • Msc in Chemical Engineering @ Rome University “La Sapienza”
Alessio Piuma linkedin Alessio Piuma mail
Alessio Piuma
Alessio Piuma
Analyst
  • Medical Devices Data Manager at A.Demori SPA
  • Researcher at IRCCS Mario Negri – Tissue Engineering Unit
  • MSc in Biomedical Engineering at Politecnico di Milano
Laura Brolis linkedin Laura Brolis mail
Laura Brolis
Laura Brolis
CFO
  • Former CFO - DGPA SGR
  • DG - Albertini SGR
  • Operations manager - Dresdner Bank AG
  • Degree in economics at Università degli Studi di Bergamo
Paola Crovato linkedin Paola Crovato mail
Paola Crovato
Paola Crovato
Office & Deal Flow Manager
  • Office Manager at Pioneer Investment Management SGR
  • Degree in economics at Università del Sacro Cuore di Milano
   

Advisors

  • Antonello Biscini

    Antonio Biscini VP Biz Dev MENARINI

    Antonio heads Business Development & Licensing at Menarini, the largest Italian pharmaceutical group with over 4.2b$ sales in 2013

  • Cogliati Gabriele

    Gabriele Cogliati Founder and CEO ELEMASTER

    Gabriele has built and leads the Italian leader in designing and developing electronic technologies for command, control and regulation devices of medical use

  • Laura Iris Ferro

    Laura Iris Ferro Founder and former CEO GENTIUM

    Laura is a Successful entrepreneur who has built and sold Gentium, leader in the development and of active ingredients derived from natural sources as potential therapeutic agents, sold to Jazz Pharmaceuticals for 1b$ in 2013

  • Emanuele Gatti

    Emanuele Gatti Former CEO EMEA and Board Member FRESENIUS MEDICAL CARE

    Emanuele has a life-long experience in the dialysis and kidney failures business, serving for almost 20 years as top Executive and Board Member in Fresenius, a dialysis global leader

  • Giuseppe Prisco

    Giuseppe Prisco Former Managing Principal INTUITIVE SURGICAL

    Giuseppe led the technical R&D efforts at Intuitive Surgical in its very early days, a company who is now the undiscussed leader in medical robotic, with a mkt cap of 18b$

  • Lorenzo Tallarigo

    Lorenzo Tallarigo Former Board Member of INTERCEPT and executive of ELI LILLY

    Lorenzo has played a key role in the Intercept story since its early days as a member of the board and as lead investor. Intercept is now a public company with a market cap over 4b$. Lorenzo has also an extensive carrier as an Executive in leading Life Sciences companies

  • Maurizio Colombo

    Maurizio Colombo Founder of Sapio Group and President of Sapio Life

    Maurizio is an entrepreneur at the forefront of the innovation in the sectors of gases and of the services related to Hospital and remote Patient Assistance.

  • Lucio Rovati

    Lucio Rovati Founder of Rottapharm and CEO / CSO of Rottapharm Biotech

    Lucio is a successful entrepreneur and experienced CSO, who has built Rottapharm, leader in research, development, manufacturing, global marketing and distribution of branded clinically proven consumer healthcare products, reimbursed prescription products and natural extracts.and of active ingredients derived from natural sources as potential therapeutic agents, sold to Meda for 3.1b$ in 2014

   

Industrial, Financial and Academic Partners

Industrial

Academic

Financial

European Investment Fund & European Commission
Panakes is supported by the INNOVFIN SME Venture Capital with the financial backing of the European Union under Horizon 2020 Financial Instruments established under Regulation (No) 1291/2013 of the European Parliament and the Council establishing Horizon 2020 – the Framework Programme for Research and Innovation (2014-2020)][through financial backing of the European Union under the Equity Facility for Growth established under Regulation (EU) No 1287/2013 of the European Parliament and the Council establishing a Programme for the Competitiveness of Enterprises and small and medium enterprises (COSME) (2014-2020)

view
   

Portfolio

www.echolight.it Echographic approach for osteoporosis early diagnosis

www.vivasuremedical.com Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures

Seventeen

Medical device and methodology for tumor treatment

   

News

Galway, Ireland, 7 September 2016


Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States

Milan, 6 September 2016


Seventeen, a startup aiming to disrupt loco-regional therapies for solid tumors, raised a Series A for more than €4 million

Milan, 21 July 2016


Medtech Startup Echolight Raises €4M in Series A Funding

Milan, 8 march 2016


Panakès Partners SGR announces the arrival of Barbara CASTELLANO as part of the investment team

Milan, 15 February 2015

Partners SGR launches its first Venture Capital Fund dedicated to European Medtech startups.
   

Contact Us

  • twitter
  • linkedin
  • Panakes Partners Panakes Partners
    Via Boscovich 31
    20124 - Milano
    contact@panakes.it

  • To submit a deal To submit a deal
    deal@panakes.it
  • To Arrive To Arrive
    5 minutes from the central station
    20 minutes from Linate Airport